Navigation Links
Novadaq to present at Piper Jaffray Healthcare Conference
Date:11/20/2007

lows surgeons to differentiate between healthy and cancerous tissue in the lung during thoracic surgery. Novadaq is also the exclusive United States distributor of PLC Medical's CO(2) HEART LASER(TM) System for TMR (Trans-Myocardial Revascularization). For more information, please visit the company's website at http://www.novadaq.com.

Certain statements included in this press release may be considered forward-looking. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements, and therefore these statements should not be read as guarantees of future performance or results. All forward-looking statements are based on Novadaq's current beliefs as well as assumptions made by and information currently available to Novadaq and relate to, among other things, anticipated financial performance, business prospects, strategies, regulatory developments, the market entry (and timing thereof) of additional suppliers of ICG, market acceptance and future commitments for the PINPOINT endoscopic imaging system and other Novadaq devices. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Due to risks and uncertainties, including the risks and uncertainties identified by Novadaq in its public securities filings; actual events may differ materially from current expectations. Novadaq disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE Novadaq Technologies Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Novadaq Resumes Normal Business Operations by Securing ICG for SPY
2. Novadaq launches PINPOINT: Companys first minimally invasive imaging system
3. Novadaq announces third quarter 2007 conference call and webcast
4. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
5. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
6. BD to Present at the Bear Stearns 20th Annual Healthcare Conference
7. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
8. Omnicell to Present at Thomas Weisel Healthcare Conference 2007
9. AtriCure to Present at Roth Capital Partners 2007 New York Conference
10. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
11. MDS to Present at Thomas Weisel Partners Healthcare Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...USNewswire/--Parties,familydinners,andothergatheri...tthemerrimentcanchangetomiseryiffoodmakesyouorothe.../prnh/20090824/FDALOGO ) ,, Typicalsymptomsoffo...toms,whichcanstartanywherefromhourstodaysaftercont...sisthatpracticingfourbasicfoodsafetymeasurescanhel...
(Date:11/24/2009)...USNewswire/--IPROhasachieveditsthirdconsecutiveISO...dardfocusedonfulfillingcustomerrequirements,enhanc...nessperformance.CertificationtoISO9001:2008bySGSIn...ManagementSystem(QMS)haspassedarigorousexternalaud...ndAlbany,NewYorkaswellasatitsaffiliateLogiqual,LLC...
(Date:11/24/2009)...--Mostpeoplelookforwardtokickingofftheholidayseaso...andfamily.TheMacombCountyHealthDepartmentremindsyo...elingandbeinginlargegroupsareeasywaystospreadfluge... VACCINATION ,, Thefirstandmostimportantstepis...ainsttheH1N1strainoftheflu.TheMacombCountyHealthDe...
(Date:11/24/2009)...ire/--Nextmonth,UnitedHealthcarewilloffertwofreeMe...icanseniorsunderstandthebasicsofMedicare.Following...74;Goldclass,aLatin-infusedfitnessprogramthatblend... ,, UnitedHealthcarewilloffertheseseminarsinSpa...rningabouttheirhealthcareoptions. Thereareapproxi...
(Date:11/24/2009)...l/--CenteneCorporation(NYSE: CNC )todayannouncedth...neasoneoftwoCoordinatedCareOrganizationstoparticip...sippiCAN),acoordinatedcareprogramforMississippiMed...toexecuteacontractinwhichthecompanywillserveeligib...agnolia). ,, BasedinJackson,Miss.,Magnoliawillw...
Breaking Medicine News(10 mins):Health News:FDA Consumer Health Information: Food Safety Tips for Healthy Holidays 2Health News:IPRO Earns Third Consecutive Quality Management Certification 2Health News:Tips To Enjoy a Flu-Free Holiday Season 2Health News:UnitedHealthcare To Offer Seniors Hispanic-Centered Medicare Education Seminars Combined With a Latin-Themed Fitness Program 2Health News:Centene Corporation Receives Notification of Intent to Contract From the State of Mississippi 2
... Chicago, Ill.--The interaction of sex, age and e...val in metastatic colorectal cancer (MCRC) patient... Southern California (USC) and USC/Norris Comprehe...t gender also plays an important role in overall s...
... The passing of time makes ovaries lose their abi...rmones which regulate the menstrual cycle. In this...sical and psychical changes such as hot flushes, s...ain, the average age for the cessation of the mens...
...ETROIT, May 29 Caraco Pharmaceutical,Laboratories...he fourth,quarter and the year ended March 31, 200...ion, respectively, as compared to $32.7 million an...08,respectively, as compared to net income of $9.5...
...merifit Brands Educates Consumers about Urinary He... realize its,prevalence, urinary tract infections ...n in the body, and account for more than 8 million...lifetime.(2),However, many women do not realize th...
...esearch adds to what is known about relationship b... The risk of developing,type 2 diabetes in women ...ow cardiorespiratory fitness or higher Body Mass I... American,College of Sports Medicine (ACSM). An in...
...air of studies features biomechanical analysis of ...flip-flops as their primary footwear option during...and a change in their stride, according to,researc...s study began with the observation,that most peopl...
Other Medicine News:Health News:USC study finds sex, age and ethnicity assciated with colorectal cancer survival 2Health News:Post-menopausal therapy to improve women's quality of life 2Health News:Caraco Pharmaceutical Laboratories, Ltd. Reports Record Results for the Fourth Quarter and Fiscal Year 2008 2Health News:Caraco Pharmaceutical Laboratories, Ltd. Reports Record Results for the Fourth Quarter and Fiscal Year 2008 3Health News:Caraco Pharmaceutical Laboratories, Ltd. Reports Record Results for the Fourth Quarter and Fiscal Year 2008 4Health News:Caraco Pharmaceutical Laboratories, Ltd. Reports Record Results for the Fourth Quarter and Fiscal Year 2008 5Health News:Caraco Pharmaceutical Laboratories, Ltd. Reports Record Results for the Fourth Quarter and Fiscal Year 2008 6Health News:Caraco Pharmaceutical Laboratories, Ltd. Reports Record Results for the Fourth Quarter and Fiscal Year 2008 7Health News:Caraco Pharmaceutical Laboratories, Ltd. Reports Record Results for the Fourth Quarter and Fiscal Year 2008 8Health News:AZO Answers the Burning Question: What's Up Down There? 2Health News:AZO Answers the Burning Question: What's Up Down There? 3Health News:AZO Answers the Burning Question: What's Up Down There? 4Health News:Studies Define Type 2 Diabetes Risk Factors in Women, Adolescents 2Health News:Studies Define Type 2 Diabetes Risk Factors in Women, Adolescents 3Health News:Studies Define Type 2 Diabetes Risk Factors in Women, Adolescents 4Health News:Flip-Flops, Heels Examined for Performance, Impact 2Health News:Flip-Flops, Heels Examined for Performance, Impact 3
(Date:11/24/2009)...TSBURGH,Nov.24/PRNewswire/-- ,, WHAT:RomHoubens...winganautoaccident,wasactuallyfullyconsciousandawa...icasegment.TheDynaVoxEyeMaxwasfeaturedinthesegment...conditionscanunlockcommunication. ,, WHEN:GoodM...at www.dynavoxtech.com ,, WHO:RomHoubens...
(Date:11/24/2009)...DCLIFFLAKE,N.J.andNEWYORK,Nov.24/PRNewswire/-- Ei...dDrugAdministration(FDA)hasacceptedforreviewEisai,...74;(donepezilHClextendedrelease)tabletsforthetreat...ewhigherdoseformulationcontains23mgofdonepezilHCli...ystemthatallowsforgradualreleaseofthedrug.TheNDAis...
(Date:11/24/2009)...EIGH,N.C.,Nov.24/PRNewswire/--PharmaceuticalInstit...forthepharmaceuticalandbiotechindustry,todayannoun...ace .Thenew HospitalMarketplace e-courseisthenewes...M) series,acomprehensiveseriesofe-coursesdesignedt...etsknowledgeforcommercialprofessionals. ,, Then...
Breaking Medicine Technology:DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 2FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 3Pharmaceutical Institute Launches New Training Resource Focused on the Hospital Marketplace 2Brain Training Keeps Older Drivers Safe Behind the Wheel 57315 1Brain Training Keeps Older Drivers Safe Behind the Wheel 57315 2Brain Training Keeps Older Drivers Safe Behind the Wheel 57315 3BioSpecifics Technologies Corp Stock Trading Halted Today 14076 1GENova and TheraGlass in advanced negotiations 57312 1GENova and TheraGlass in advanced negotiations 57312 2GENova and TheraGlass in advanced negotiations 57312 3
...--May 2, 2007 - Acorda Therapeutics, Inc.(R),(Nasd...ical trial,of Fampridine-SR in people with multipl...ogy meeting. Andrew Goodman, M.D.,Director of the...chester, presented top-line results on walking abi...ubject global impressions.,Dr. Goodman also presen...
...May 02, 2007 /PRNewswire-FirstCall/ --,Genelabs Te...on was,made today at the 20th International Confer...ngs, California, on a,non-nucleoside hepatitis C v...labs. , The oral presentation was given by Christo...istry at Genelabs, entitled,"GL59728: A Potent All...
Other Medicine Technology:Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 2Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 3Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 4Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 5Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 6Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 7Genelabs Technologies Announces Presentation of Data on,Non-Nucleoside HCV Polymerase Inhibitor at 20th International,Conference on Antiviral Research Meeting 2Genelabs Technologies Announces Presentation of Data on,Non-Nucleoside HCV Polymerase Inhibitor at 20th International,Conference on Antiviral Research Meeting 3
Near Point Card/Newspaper 8 to 48 - BC2203
Near Point Diagnostic Card Set - BC11982
Near Point Card 4 1/2 to 24 PT - BC2202
... references to many common print sizes, from newsp...size. This provides the examiner a starting point ... black ink on yellow styrene for increased contras.... Other notations include Jaeger, M notation, lowe...
Medicine Products: